Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

静安 - NMPA Drug Approval Details

Approvals/NMPA/Propofol Injectable Emulsion

Approved

化学药品

Propofol Injectable Emulsion

Fresenius Kabi Deutschland Gmbh🇨🇳 National Medical Products Administration

Approval Date: Nov 9, 2021
Approval ID: 8FWSEb5VESB
Company: Fresenius Kabi Deutschland Gmbh
Type: 化学药品

Approval Details

Approval Id: 8FWSEb5VESB
Approval Number: 国药准字HJ20170312
Generic Name: 丙泊酚乳状注射液
Generic Name En: Propofol Injectable Emulsion
Trade Name: 静安
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 50ml：1g
Reg Date: 2021-11-09
Expired Date: 2026-11-08
Company Name: Fresenius Kabi Deutschland Gmbh
Production Company Name: Fresenius Kabi Austria Gmbh
Company Detail Path: /organization/fresenius-kabi-deutschland-gmbh
Production Company Detail Path: /organization/fresenius-kabi-austria-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 9, 2021

Approval ID

8FWSEb5VESB

Type

化学药品

Back to NMPA Approvals